137 related articles for article (PubMed ID: 7492766)
1. Role of antennary structure of N-linked sugar chains in renal handling of recombinant human erythropoietin.
Misaizu T; Matsuki S; Strickland TW; Takeuchi M; Kobata A; Takasaki S
Blood; 1995 Dec; 86(11):4097-104. PubMed ID: 7492766
[TBL] [Abstract][Full Text] [Related]
2. Comparative pharmacokinetics and distribution of human urinary erythropoietin and recombinant human erythropoietin in rats.
Kinoshita H; Ohishi N; Kato M; Tokura S; Okazaki A
Arzneimittelforschung; 1991 Sep; 41(9):1004-7. PubMed ID: 1796912
[TBL] [Abstract][Full Text] [Related]
3. Relationship between sugar chain structure and biological activity of recombinant human erythropoietin produced in Chinese hamster ovary cells.
Takeuchi M; Inoue N; Strickland TW; Kubota M; Wada M; Shimizu R; Hoshi S; Kozutsumi H; Takasaki S; Kobata A
Proc Natl Acad Sci U S A; 1989 Oct; 86(20):7819-22. PubMed ID: 2813359
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and distribution of recombinant human erythropoietin in rats with renal dysfunction.
Kinoshita H; Ohishi N; Tokura S; Okazaki A
Arzneimittelforschung; 1992 May; 42(5):682-6. PubMed ID: 1530684
[TBL] [Abstract][Full Text] [Related]
5. In vivo 125I-erythropoietin pharmacokinetics are unchanged after anesthesia, nephrectomy and hepatectomy in sheep.
Widness JA; Veng-Pedersen P; Schmidt RL; Lowe LS; Kisthard JA; Peters C
J Pharmacol Exp Ther; 1996 Dec; 279(3):1205-10. PubMed ID: 8968342
[TBL] [Abstract][Full Text] [Related]
6. Distribution of recombinant human erythropoietin following multiple intravenous administration and effects of age on the distribution in rats.
Kinoshita H; Ohishi N; Kato M; Tokura S; Okazaki A
Arzneimittelforschung; 1992 Apr; 42(4):579-84. PubMed ID: 1642686
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and distribution of recombinant erythropoietin in rats.
Kinoshita H; Ohishi N; Kato M; Tokura S; Okazaki A
Arzneimittelforschung; 1992 Feb; 42(2):174-8. PubMed ID: 1610430
[TBL] [Abstract][Full Text] [Related]
8. The in vivo metabolism of recombinant human erythropoietin in the rat.
Spivak JL; Hogans BB
Blood; 1989 Jan; 73(1):90-9. PubMed ID: 2462945
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of recombinant human erythropoietin in rabbits and 3/4 nephrectomized rats.
Yoon WH; Park SJ; Kim IC; Lee MG
Res Commun Mol Pathol Pharmacol; 1997 May; 96(2):227-40. PubMed ID: 9226757
[TBL] [Abstract][Full Text] [Related]
10. Metabolism of pure human erythropoietin in the rat.
Emmanouel DS; Goldwasser E; Katz AI
Am J Physiol; 1984 Jul; 247(1 Pt 2):F168-76. PubMed ID: 6742201
[TBL] [Abstract][Full Text] [Related]
11. Mechanism for the nonlinear pharmacokinetics of erythropoietin in rats.
Kato M; Kamiyama H; Okazaki A; Kumaki K; Kato Y; Sugiyama Y
J Pharmacol Exp Ther; 1997 Nov; 283(2):520-7. PubMed ID: 9353365
[TBL] [Abstract][Full Text] [Related]
12. The importance of N- and O-linked oligosaccharides for the biosynthesis and in vitro and in vivo biologic activities of erythropoietin.
Wasley LC; Timony G; Murtha P; Stoudemire J; Dorner AJ; Caro J; Krieger M; Kaufman RJ
Blood; 1991 Jun; 77(12):2624-32. PubMed ID: 2043765
[TBL] [Abstract][Full Text] [Related]
13. Immunological response to repeated administration of recombinant human erythropoietin in rats: biphasic effect on its pharmacokinetics.
Kato M; Miura K; Kamiyama H; Okazaki A; Kumaki K; Kato Y; Sugiyama Y
Drug Metab Dispos; 1997 Sep; 25(9):1039-44. PubMed ID: 9311618
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic study of darbepoetin alfa: absorption, distribution, and excretion after a single intravenous and subcutaneous administration to rats.
Yoshioka E; Kato K; Shindo H; Mitsuoka C; Kitajima SI; Ogata H; Misaizu T
Xenobiotica; 2007 Jan; 37(1):74-90. PubMed ID: 17178635
[TBL] [Abstract][Full Text] [Related]
15. Structures and functional roles of the sugar chains of human erythropoietins.
Takeuchi M; Kobata A
Glycobiology; 1991 Sep; 1(4):337-46. PubMed ID: 1820196
[TBL] [Abstract][Full Text] [Related]
16. N-linked sugar chain structure of recombinant human lymphotoxin produced by CHO cells: the functional role of carbohydrate as to its lectin-like character and clearance velocity.
Fukushima K; Watanabe H; Takeo K; Nomura M; Asahi T; Yamashita K
Arch Biochem Biophys; 1993 Jul; 304(1):144-53. PubMed ID: 8323280
[TBL] [Abstract][Full Text] [Related]
17. Survival of recombinant erythropoietin in the circulation: the role of carbohydrates.
Fukuda MN; Sasaki H; Lopez L; Fukuda M
Blood; 1989 Jan; 73(1):84-9. PubMed ID: 2910371
[TBL] [Abstract][Full Text] [Related]
18. The hypoxia inducible factor/erythropoietin (EPO)/EPO receptor pathway is disturbed in a rat model of chronic kidney disease related anemia.
Landau D; London L; Bandach I; Segev Y
PLoS One; 2018; 13(5):e0196684. PubMed ID: 29738538
[TBL] [Abstract][Full Text] [Related]
19. Darbepoetin alfa has a longer circulating half-life and greater in vivo potency than recombinant human erythropoietin.
Egrie JC; Dwyer E; Browne JK; Hitz A; Lykos MA
Exp Hematol; 2003 Apr; 31(4):290-9. PubMed ID: 12691916
[TBL] [Abstract][Full Text] [Related]
20. Plasma disappearance of exogenous erythropoietin in mice under different experimental conditions.
Lezón CE; Martínez MP; Conti MI; Bozzini CE
Endocrine; 1998 Jun; 8(3):331-3. PubMed ID: 9741839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
